Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches
The SARS-CoV-2 3CLpro protein is one of the key therapeutic targets of interest for COVID-19 due to its critical role in viral replication, various high-quality protein crystal structures, and as a basis for computationally screening for compounds with improved inhibitory activity, bioavailability,...
Main Authors: | Faisal Bin Ashraf, Sanjida Akter, Sumona Hoque Mumu, Muhammad Usama Islam, Jasim Uddin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479925/?tool=EBI |
Similar Items
-
Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches.
by: Faisal Bin Ashraf, et al.
Published: (2023-01-01) -
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
by: Adel S. Girgis, et al.
Published: (2023-09-01) -
In Silico Identification of Propolis Compounds Potential as COVID-19 Drug Candidates Against SARS-CoV-2 Spike Protein
by: Muhamad Sahlan, et al.
Published: (2023-04-01) -
Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry
by: Erum Zafar, et al.
Published: (2022-12-01) -
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
by: Igor de Andrade Santos, et al.
Published: (2020-08-01)